CERVIX | CERVICAL SCREENING [ISSN 1804-087X]
česky | english | sitemap


PARTNERS AND EXPERT GUARANTEE
 
Czech Gynaecological and Obstetrical Society | Ministry of Health | Institute of Biostatistics and Analyses, Masaryk University
GRANT SUPPORT OF THE PROJECT
 
GlaxoSmithKline     Roche |

Other sources of information
Cervical cytology (in Czech)www.cipek.cz
Cervical cytology
 
Cancer Screening in the European Unionec.europa.eu
Cancer Screening in the European Union (2017)
[ 10,6 MB]
 
SVOD - Epidemiology of malignant tumours in the Czech Republicwww.svod.cz
Epidemiology of malignant tumours
in the Czech Republic
 
NCI Bethesda System
HPV College

 

News for health professionals

Epidemiology of cervical cancer Screening process References

Archive

Year: 2018 | 2017 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | 2008


HPV home tests for cervical cancer prove effective in study
4.11.2011 Cancer Research UK | More information...

Self-testing for the human papillomavirus (HPV) - the virus that causes cervical cancer - at home is at least as sensitive as conventional cytology (smear testing) in detecting cervical cancer or pre-cancerous changes, a study of Mexican women has found.

Fewer than three doses of cervical cancer vaccine effective
9.9.2011 ecancermedicalscience | More information...

Fewer than three doses of the human papillomavirus (HPV) vaccine Cervarix may be just as effective as the standard three-dose regimen when it comes to preventive measures against cervical cancer, according to a new study published in the Journal of the National Cancer Institute.

HPV testing for two high-risk strains could identify women at greatest risk of cervical cancer
23.8.2011 ecancermedicalscience | More information...

Human papillomavirus (HPV) testing for the two most dangerous strains (HPV16 and HPV18) detects more high-grade pre-cancerous lesions (which can lead to cervical cancer) than current cervical cancer screening using cytology alone.

Drop in pre-cancerous cervical changes in Australia after HPV vaccination introduced
17.6.2011 Cancer Research UK | More information...

The number of women with precancerous cervical changes has fallen in Victoria, Australia since the introduction of human papillomavirus (HPV) vaccination programmes, a new study has found.

UICC: HPV and Cervical Cancer Curriculum
23.5.2011 Administrator | More information...

An e-learning tool, developed by UICC, to be used as basis for courses, workshops and self-learning, the HPV and Cervical Cancer Curriculum has been designed to improve individual knowledge on HPV and cervical cancer.

HPV and Pap co-testing study for cervical cancer screening reports
19.5.2011 ecancermedicalscience | More information...

First large study of HPV and pap co-testing in routine clinical practice confirms most women can safely extend screening to every three years; HPV testing alone also appears to be superior to pap testing alone.

Discovery of gene ripple effect which causes cervical cancer to advance and spread
18.5.2011 Cancer Research UK Press Release | More information...

Cancer Research UK scientists have discovered that a common gene fault in cervical cancer cells triggers a ripple of molecular signals - which makes the disease more aggressive, according to research published in The Journal of Pathology, today.

Good outlook for women with normal Pap smears after treatment for cervical lesions
28.4.2011 ecancermedicalscience | More information...

Good news for women treated for precancerous cervical lesions. A Dutch study published in Lancet Oncology shows that after three consecutive normal cytological smears (Pap tests) women face a similar 5-year risk of developing cervical cancer or recurrent disease to the general population and can return to population-based regular screening.

'Patchwork' of gene faults could help predict cervical cancer drug success
19.1.2011 British Journal of Cancer Press Release | More information...

Cancer Research UK scientists have discovered that cervical cancer patients who have a mixture of different genetic faults in their tumour at the start of treatment may be more likely to relapse, according to a study published in the British Journal of Cancer today.

HPV testing to be included in NHS cervical screening programme
13.1.2011 Cancer Research UK | More information...

The inclusion of human papillomavirus (HPV) testing in the current NHS Cervical Screening Programme from April 2011 has been confirmed in the programme's annual review, which was published last Friday (January 7th). The HPV test - which looks for the presence of certain high-risk strains of the human papillomavirus - will be offered to women with borderline or low-grade cervical abnormalities detected in the first round of cervical screening.


Back